Superstring Capital Management »

United Therapeutics Corporation shares owned by Superstring Capital Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Superstring Capital Management from 13F filings

Historical chart of Superstring Capital Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Superstring Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Superstring Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.6M 9.5k 487.25
2025-06-30 $1.4M 4.9k 287.35

More positions owned by Superstring Capital Management

Cidara Therapeutics Com New (CDTX)
Terns Pharmaceuticals (TERN)
Urogen Pharma (URGN)
Cogent Biosciences (COGT)
Dynavax Technologies Corp Com New (DVAX)
Sionna Therapeutics (SION)
Immunovant (IMVT)
Axsome Therapeutics (AXSM)
Savara (SVRA)
Mind Medicine Mindmed Com New (MNMD)
Taysha Gene Therapies Com Shs (TSHA)
Ocular Therapeutix (OCUL)
Amicus Therapeutics (FOLD)
Cabaletta Bio (CABA)
United Therapeutics Corporation (UTHR)

View all positions for Superstring Capital Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation